AI brief of an SEC Form 8-K · Versigent (VGNT)
Versigent Q3 net sales up 7.2% to $2.45 billion; raises full-year sales guidance
Versigent reported third-quarter 2026 net sales of $2.45 billion, up 7.2% year over year, but net income attributable to Versigent fell to $102 million from $109 million and diluted EPS fell to $1.41 from $1.54. The company raised the midpoint of its full-year net sales guidance and raised the upper end and midpoint of its free cash flow guidance, while tightening those ranges and its Adjusted EBITDA range.
Key points
- Q3 2026 net sales of $2,450 million, up 7.2% year over year; Adjusted Net Sales Growth of approximately 1%
- Diluted EPS of $1.41 vs. $1.54 a year earlier; Adjusted Diluted EPS of $1.91 vs. $1.81
- Full-year 2026 net sales guidance narrowed to $9,500-$9,600 million from $9,400-$9,600 million; free cash flow guidance raised to $275-$325 million from $200-$300 million
- Board declared a quarterly cash dividend of $0.13 per share, payable December 17, 2026
The filing
CompanyVersigent (VGNT)
Form8-K, current report
Filed with the SECNov 4, 2026, 6:46 AM ET
Accession number0002078008-26-000023
Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.